One of the outpatient treatment alternatives for individuals in Rosedale battling with opioid abuse and addiction is opioid maintenance therapy. Some centers and doctors are authorized to administer certain medications to opioid dependent individuals, many that are opioids themselves and are habit forming. In low enough doses the user does not experience being high but also does not experience severe cravings and isn't in opioid withdrawal. Methadone is the first drug administered for this sole purpose, but there are alternative options to select from.
Methadone is an opiate and is meant to be taken at an outpatient clinic licensed to dispense the med, which is taken daily in liquid or pill form. The cost of the med is about $150 a month. Buprenorphine is also an opiate based drug, and is in pill form often taken one day on, one day off. But different from Methadone which can only be dispensed in highly well-regulated clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is around just under $300 a month for the generic version of the drug. There is also a version of buprenorphine that contains naloxone, that is a med that reverses the effects of opiates. Someone consuming this version of the drug, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken every day, and is priced around $450 per month. Naltrexone is an additional drug taken in opioid maintenance therapy, but unlike the other drugs mentioned here it is an opioid blocker and is not an opiate. A person has the choice to take this drug as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents someone from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 /month.
There are 1 Drug and Alcohol Rehabilitation Facilities offering this service in Rosedale, MD
For All Drug and Alcohol Treatment Centers In Rosedale, Click Here.